| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.1B | $11.7B | $14.4B | $12.7B | $11.1B | $9.1B | $9.0B | $9.4B |
| Cost of Revenue | $7.5B | $8.8B | $10.6B | $9.7B | $8.6B | $7.1B | $7.1B | $7.4B |
| Gross Profit | $2.6B | $2.9B | $3.8B | $3.0B | $2.6B | $2.1B | $2.0B | $2.0B |
| R&D Expense | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.4B |
| SG&A Expense | $1.3B | $1.4B | $1.5B | $1.2B | $1.1B | $1.0B | $1.0B | $1.1B |
| Operating Income | $0.6B | $-0.1B | $1.7B | $1.3B | $1.0B | $0.6B | $0.3B | $0.5B |
| Net Income | $0.7B | $-0.4B | $1.2B | $0.9B | $0.9B | $0.4B | $0.1B | $0.3B |
| EPS (Basic) | $9.76 | $-5.69 | $15.66 | $11.92 | $11.93 | $5.69 | $1.64 | $3.62 |
| EPS (Diluted) | $9.75 | $-5.69 | $15.63 | $11.87 | $11.85 | $5.65 | $1.63 | $3.58 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.9B | $11.2B | $11.4B | $10.1B | $9.2B | $8.5B | $7.8B | $7.6B |
| Current Assets | $5.2B | $5.1B | $6.3B | $5.7B | $5.0B | $4.4B | $3.7B | $3.5B |
| Cash & Equivalents | $0.9B | $0.6B | $0.6B | $0.8B | $0.9B | $1.1B | $0.4B | $0.3B |
| Total Liabilities | $7.4B | $7.1B | $6.8B | $6.2B | $5.7B | $5.5B | $4.9B | $4.6B |
| Current Liabilities | $3.7B | $3.8B | $4.3B | $4.1B | $3.5B | $3.4B | $2.9B | $2.8B |
| Stockholders' Equity | $4.3B | $3.7B | $4.7B | $3.9B | $3.4B | $3.0B | $2.9B | $2.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.7B | $1.1B | $0.8B | $0.7B | $0.9B | $0.7B | $0.6B |
| Investing Cash Flow | $-0.0B | $-1.7B | $-0.5B | $-0.5B | $-0.3B | $-0.2B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.2B | $0.4B | $0.5B | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B |
| Financing Cash Flow | $-0.7B | $1.0B | $-0.7B | $-0.4B | $-0.5B | $0.0B | $-0.3B | $-0.4B |